Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
0
Number of overlapping holdings
0.0%
% of XPH's 39 holdings also in PPH
nan%
% of PPH's 26 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PPH
 |
ELANCO ANIMAL HEALTH, INC. | 5.2% |
|
ELI LILLY & CO | 5.1% |
|
INTRA-CELLULAR THERAPIES INC | 5.1% |
|
ZOETIS INC | 4.9% |
|
JOHNSON & JOHNSON | 4.8% |
|
MERCK & CO. INC. | 4.7% |
|
ROYALTY PHARMA PLC CLASS A | 4.7% |
|
VIATRIS, INC. | 4.7% |
 |
PERRIGO CO | 4.6% |
|
JAZZ PHARMACEUTICALS PLC | 4.5% |
XPH Underweight Relative to PPH
|
ACLARIS THERAPEUTICS, INC. | 0.1% |
|
VENTYX BIOSCIENCES, INC. | 0.2% |
|
PHATHOM PHARMACEUTICALS, INC. | 0.3% |
|
OCULAR THERAPEUTIX INC | 0.4% |
|
EVOLUS, INC. | 0.6% |
 |
THERAVANCE BIOPHARMA INC | 0.6% |
|
IMPRIMIS PHARMACEUTICALS INC | 0.7% |
|
BIOSANTE PHARMACEUTICALS INC | 0.7% |
|
TARSUS PHARMACEUTICALS, INC. | 0.8% |
|
LIGAND PHARMACEUTICALS-CL B | 0.9% |